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Abstract 
The purpose of the present work was to study the acute regulation of glucose uptake in cultured cardiac endothelial cells (CEC). Two 
types of potential stimuli were considered: (1) agents that are known to acutely stimulate glucose transport (i.e., within minutes) in fat and 
muscle tissues and (2) agents that influence endothelial cell function. Among the former agents, neither insulin, nor catecholamines 
(adrenaline, dopamine, phenylephrine), nor serotonin affected the rate of glucose transport in CEC, while SH-group reagents (phenyl- 
arsine oxide, diamide or menadione) were inhibitory. Among the factors of the second group that were tested (heparin, ADP, histamine, 
bradykinin), histamine was found to stimulate glucose transport in CEC by 10-50%. This effect was concentration-dependent (with an 
ECso value - 12 /xM) and reached a maximum within 5 min upon histamine addition. This stimulation of glucose transport was 
suppressed by pyrilamine (100 nM), a specific Hi-receptor antagonist, but not by cimetidine (100 /xM), a H2-selective antagonist. 
Northern blot and Western blot analysis of CEC extracts revealed the presence of the ubiquitous glucose transporter isoform GLUT1 
mRNA and protein, but not of the 'insulin-regulatable' isoform GLUT4. In conclusion, this is the first report on an acute stimulation of 
glucose transport in cardiac endothelial cells, in particular, and in an insulin-unresponsive c ll type, in general. The effect of histamine is 
most likely mediated by Hrreceptors and cannot be accounted for by a recruitment of GLUT4. 
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1. Introduction 
Glucose is the major substrate of energy metabolism in 
endothelial cells [1]. An increase in the rate of glucose 
uptake was reported to occur upon long-term treatments 
(i.e., over hours) such as glucose deprivation [2], hypoxia 
[3] or exposure to growth factors [4]. These effects are 
accounted for by an up-regulation of the glucose trans- 
porter isoform GLUT1 at the transcriptional level [2-4]. 
Although endothelial cells are subject o acute challenges, 
such as in the vascular responses to injury, infection or 
shear stress, which might also influence endothelial cell 
energy metabolism, knowledge about a rapid regulation of 
Abbreviations: dGlc, 2-deoxy-D-glucose; CEC, cardiac endothelial 
cells. 
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glucose transport and metabolism in these cells is very 
scarce. The possibility of such a short-term control was 
suggested on the basis of immunocytochemical investiga- 
tions by Vilaro et al. [5]. These authors reported that 
endothelial cells of fat, muscle and heart tissues not only 
express the 'insulin-regulatable' glucose carrier isoform 
GLUT4, but also respond to an insulin administration i  
vivo with a translocation of GLUT4 to the plasma mem- 
brane [5]. In contrast, endothelial cells of liver and brain 
(tissues that do not respond to insulin with respect to 
glucose transport) do not contain GLUT4 [5]. In cultured 
endothelial cells, long-term [6-8], but not short-term [2,4] 
stimulatory effects of insulin on glucose transport were 
detected. Since the cells used in these latter studies were 
obtained from insulin-unresponsive tissues such as brain 
[2] or aorta [4], extrapolation of the findings to insulin-re- 
sponsive organs such as the heart [9,10] should be done 
with precaution. We therefore examined the effect of 
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insulin on glucose transport in cultured endothelial cells 
obtained from adult rat heart. Furthermore, we tested the 
action (1) of agents known to mimic the effect of insulin in 
adipocytes and myocytes, such as SH-reagents [11-15], 
catecholamines [9,16,17] or serotonin [16] and (2) of regu- 
lators of endothelial cell function, such as bradykinin 
[18-21], histamine [22-24], heparin [25,26] or adenosine 
diphosphate [27,28]. 
2. Materials and methods 
2.1. Mater ia l s  
2-Deoxy-D-[3H]glucose was purchased from Amersham 
(Braunschweig, FRG); culture medium RPMI 1640, M 
199, Penicillin, Streptomycin Gentamycin, Fungizon, 
trypsin (Gibco); collagenase (Cooper Biomedical, Wor- 
A 
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Fig. 1. Characterization of cardiac endothelial cells (CEC) in culture. CEC were grown as described inSection 2and used in the experiments presented in 
Section 3. Shown are representative parallel samples identifying the cultured cells as truly endothelial. A: Light micrograph of confluent monolayer 
(magnification 25 X ); B: Positive staining with DiI-Ac-LDL by the method of Voyta et al. [30] (magnification 15 X ); C: positive staining with 
von-Willebrand factor (factor Villi) by the method of Jaffe [31] (magnification 25× ). 
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thington); BSA, FCS, ADP (Boehringer Mannheim); fi- 
bronectin (Red Cross of the Netherlands); Dil-Ac-LDL 
(Biomedical Technologies, Stoughton USA); Anti-vWF 
(Dakopatts, Copenhagen); RECA1 was a kind gift from 
Dr. A. Duijvstijn (University of Limburg, Maastricht); 
phloretin, Na-heparin (Serva, Heidelberg); bovine insulin 
was a kind gift from Prof. A. Wollmer (Aachen), phenylar- 
sine oxide, 2-deoxy-o-glucose (dGlc), diamide, mena- 
dione, serotonin, adrenaline, dopamine, phenylephrine, 
bradykinin (Sigma), histamine (RBI). 
2.2. Endothelial cell isolation and culture 
Isolation of cardiac endothelial cells (CEC), cultivation 
and characterization were carried out as described by 
Linssen et al. [29]. Briefly, hearts from 12-week-old male 
Lewis rats were perfused for 30 min with collagenase 
solution by the Langendorff procedure and CEC collected 
from the effluent by centrifugation; the cells were resus- 
pended and washed once before they were plated on 
fibronectin-coated Petri dishes. After ca. 10 days cells had 
grown to confluence and were subcultured as follows: they 
were detached by trypsin treatment, resuspended in fresh 
culture medium, plated on fresh precoated ishes in a ratio 
of 1:3, and were allowed to grow to confluence. For the 
experiments, nearly confluent cells from the third or fourth 
passage were used. These cells were characterized (1) by 
their morphology (Fig. 1A), (2) by their ability to take up 
the low density lipoprotein derivative Dil-Ac-LDL [30] 
(Fig. 1B), (3) by immunocytochemical detection of von- 
Willebrand-factor [31] (Fig. 1C) and (4) of a rat endothe- 
lial cell specific antigen [32] by fluorescence microscopy 
(not shown). 
2.3. Glucose transport assay 
Three hours prior to the experiments the culture medium 
was removed and the cells were washed with phosphate- 
buffered saline (PBS; containing 0.9 mM Ca 2÷ and 0.5 
mM Mg 2+) before Hanks' balanced salt solution (HBSS, 
pH 7.4) containing 4% BSA was added. Immediately 
before the assay, the cells were washed twice with 1 ml 
glucose-free HBSS. They were incubated in a final volume 
of 950 /xl glucose-free HBSS either in the absence (con- 
trol) or in presence of the agents to be tested for the 
indicated times (typically 15 min) at room temperature. 
2-Deoxy-D-glucose (dGlc) transport was then measured by 
adding 50 /zl of a solution containing 2 /~Ci 2-deoxy-o- 
[3H]glucose and unlabelled Glc (final concentration in the 
assay: 50/zM). After a period of 15 min (during which the 
uptake of dGlc was found to be linear; Fig. 2), transport 
was stopped by quickly removing the supernatant and 
washing the cell monolayer three times with ice-cold 
HBSS (containing 400 /xM phloretin, a specific inhibitor 
of carrier-mediated glucose transport). The cells were solu- 
bilized in 0.5 ml 0.1 N NaOH/0.1% SDS and radioactiv- 
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Fig. 2. Time course of dGlc uptake by CEC. Cells were preincubated for 
the indicated time interval in the presence ([]) or absence (• )  of the 
glucose transport inhibitor phloretin (400 /xM) in glucose free HBSS, 
before the amount of cell-bound radioactivity was determined as de- 
scribed in Section 2. Values are means + S.E.M. from 2-5 independent 
experiments (each experiment in triplicate). 
ity was counted in a liquid scintillation counter (Philips). 
The protein content was measured in parallel samples 
according to the method of Lowry [33]. 
Specific, i.e., glucose-carrier mediated uptake was de- 
termined by subtracting uptake rates measured in the pres- 
ence of 170 ~M phloretin from values measured inmedium 
without phloretin. In each individual experiment, values 
were determined in triplicate. 
2.4. Immunochemical detection of glucose transporters 
GLUT1 and GLUT4 by Western blot 
After grown to confluence, cells were harvested with a 
rubber policeman in a homogenisation buffer containing: 
Hepes (25 mM), EDTA (4 raM), aprotinin (1 U/ml), 
benzamidine (25 mM), PMSF (0.2 raM), leupeptin (1 
/zM), pepstatin (1 /xM) and sucrose (250 mM) (pH 7.4). 
Cell were sonified (Branson Sonifier, Branson, Soest, 
FRG) and than minced 30 times in a glass/glass-homo- 
genisator. To obtain a crude membrane fraction, the ho- 
mogenate was centrifuged for 10 min at 4 ° C at 10000 × g 
(Sorvall, SS34, Bad Nauheim, FRG). The supernatant was 
centrifuged again for 2 h at 4 ° C at 200000 X g (Beck- 
mann, Ti70, Fullerton, CA, USA). The resulting pellet was 
resuspended in a buffer containing Tris (10 mM), EDTA 
(0.1 mM) and SDS (2% w/v) (pH 7.5). After SDS-PAGE 
(10% gel), the proteins were transferred by semi-dry-blot- 
ting (Bio-Rad, Munich, FRG) to PVDF (polyvinylidine 
difluoride) membranes (Millipore, Eschborn, FRG). The 
membranes were blocked in 10% milk/PBS, 0.05% Tween 
20 (pH 7.5) for 90 rain and then incubated overnight with 
anti-GLUT1 or anti-GLUT4 antibodies (Calbiochem, Bad 
Soden, FRG) in 10% milk/PBS (pH 7.5) at room tempera- 
ture. A crude membrane fraction from rat brain, or from 
rat heart were used as GLUT1- or as GLUT4-containing 
control, respectively. After 4 washings with PBS/0.05% 
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Tween 20 (pH 7.5) the membranes were incubated for 4 h 
at room temperature with 125I-Protein A. They were then 
washed 6-7 times with TTBS: NaC1 (137 mM), Tris (20 
mM), CaC12 (2 mM), 0.05% Tween 20 (pH 7.6) and 
analyzed by autoradiography. 
2.5. Northern blot analysis o f  GLUT1 and GLUT4 mRNA 
The isolation of RNA was performed by the method of 
Chomczynski and Sacchi [54]. In brief, CEC were de- 
tached by trypsin treatment, centrifuged and dissolved in 
buffer containing guanidine isothiocyanate (4 M), sodium 
citrate (25 mM, pH 7.0), N-lauroylsarcosin 0.5%, /3-mer- 
captoethanol (0.1 M). After extraction (twice) with phe- 
nol /chloroform at acidic pH (~ 4.0) and precipitation 
with 2-propanol, the dry RNA pellet was dissolved in 
sterile water and analyzed by spectrophotometry. For 
long-term storage at -80  ° C, Rnasin and dithiothreitol 
were added. 
20 ~g of each sample were subjected to formamide-for- 
maldehyde gel electrophoresis (in 40 mM MOPS, 10 mM 
sodium acetate, 1 mM EDTA (pH 7.0), overnight run at 
4 ° C at 50 mA). The RNA was transferred to a Hybond 
N + nylon membrane (Amersham, Braunschweig, FRG) 
with capillary blot in 20 × SSPE buffer (3.6 M NaC1, 0.2 
M NaH2PO4, [20] mM EDTA [pH 7.7]). After UV-fixa- 
tion and baking (2 h, 80 ° C) the membranes were prehy- 
bridized in 5 X SSPE buffer supplemented with 5 x 
Denhardt's (0.1% bovine., serum albumin, 0.1% Ficoll, 
0.1% polyvinylpyrrolidone, 0.5% SDS, 50% (v /v )  for- 
mamide and 50 /xl of denatured salmon sperm DNA) for 
at least 2 h at 42 ° C. 
A 1.9 kb GLUT1 cDNA and a 1.5 kb GLUT4 cDNA 
fragment (~ 100 ng each; kindly provided by Prof. H.G. 
Joost, Aachen, FRG) were random primed labelled with 
ce-a2p-dATP (25 /zCi per sample; purchased from NEN, 
Bad Homburg, FRG; labelling kit from Boehringer 
Mannheim, FRG). Hybridization was carried out overnight 
at 42 ° C. The membrane,; were washed twice with 2 × 
SSPE at room temperature, once with 1 × SSPE at 50 ° C, 
dried and exposed to a hyperfi lm-MP (Amersham, FRG). 
The same blot membranes were prehybridized again, and 
then hybridized with a PCR generated fragment of a 
glyceraldehyde phosphate dehydrogenase (GAPDH) cDNA 
(which was a kind gift from Dr. Helga Rothe, Diisseldorf, 
FRG). The conditions of labelling, hybridization and wash- 
ings were the same as for those described above. 
3. Results 
Table 1 
Effect of insulin, SH-group reagents, catecholamines, and known effec- 
tors of endothelial cell function, on dGlc uptake in CEC 
Addition Agent Relative dGlc Significance 
Concentration transport ate (vs. control) 
(% of control) 
None (control) - 100 
Insulin (30 min) 10 nM 96.3 + 22.8 
(60 min) 93.5 -1- 6 
(90 min) 100+ 17 
Insulin (30 min) 100 nM 104 + 10 
Phenylarsine oxide 0.5/xM 100+7 
3 /zM 69 + 8 p = 0.08 
10/xM 44+9 p = 0.01 
30/xM 16-1-4 p < 0.001 
Diamide 10 p.M 114 _+ 9 p = 0.18 
30/xM 104+9 
300/xM 70_+5 p = 0.053 
1 mM 47 5= 1 p = 0.006 
Menadione 10/xM 117-+ 17 p = 0.25 
30/xM 63 -+ 13 p = 0.035 
100/~M 48+3 p = 0.009 
Adrenaline 100/xM 91 -+ 11 
Dopamine 100/xM 102_ 2 
Phenylephrine 100/xM 103-+ 13 
Serotonin 100/.LM 97 _+ 1 
Bradykinin 1 /xM 100+6 
10/xM 107-+ 10 
Heparin 20 U/ml 92 -+ 4 
ADP 10/zM 1155:15 P = 0.25 
Histamine (5 min) 100 ~M 125 -+ 8 P = 0.028 
(15 min) 100 /zM 132+3 P < 0.001 
(30 min) 100/xM 123-+ 1 P < 0.001 
Cells were preincubated for 15 min in the absence (control) or in the 
presence of one of these agents at the indicated concentrations before 
dGlc uptake was measured over a period of 15 min as described in 
Section 2. With insulin the preincubation time ranged between 30 and 90 
min, as indicated. Additional samples were treated 5 or 30 min with 
histamine, as indicated, the cells were then rapidly washed (once) and 
dGlc uptake was measured over a period of 2.5 min. Data are means _+ 
S.E.M. from 2-4 independent experiments (n= 3 in each individual 
experiment). Statistical significance vs. control was calculated with a 
paired Student's t-test. 
time of 15 min (in the presence of dGlc) was therefore 
chosen for all the experiments described below. In the 
presence of phloretin (400 /xM), a specific inhibitor of 
glucose transport, the uptake rate of dGlc is about 20% of 
the value measured in the absence of this inhibitor (Fig. 2), 
indicating that a major part of the sugar enters the cells via 
a glucose carrier. In control CEC, carrier-mediated glucose 
uptake amounts to 347 _ 33 pmol per mg protein per min 
(mean from 31 independent exper iments_  S.E.M.). This 
range is similar to values measured by others in CEC [8] or 
in another type of endothelial cells in culture, namely 
bovine aortic endothelial cells [4]. 
3.1. Carrier-mediated glucose transport in CEC 
Under the experimenta] conditions described in Section 
2, the rate of 2-deoxy-D-glucose (dGlc) uptake in CEC is 
linear for at least 20 min (Fig. 2). A standard incubation 
3.2. Effect of  insulin, SH-group reagents, catecholamines 
and serotonin on glucose transport 
In a first set of experiments, we tested the influence of 
insulin on the rate of glucose transport. As shown in Table 
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1, neither a preincubation of CEC with insulin (10 nM) for 
up to 90 min, nor a supraphysiological insulin concentra- 
tion (100 nM) resulted in a stimulation of glucose transport 
in these cells. We also investigated the possible influence 
of other agents known to stimulate glucose transport in 
insulin-responsive c lls, such as adipocytes or myocytes: 
SH-group reagents [11-15], catecholamines [9,16,17] and 
serotonin [16]. The results of the experiments in CEC are 
summarized in Table 1. SH-group reagents, such as pheny- 
larsine oxide, diamide and menadione, decrease the rate of 
dGlc transport to about 50% of control values, at concen- 
trations that markedly stimulate glucose transport in car- 
diac myocytes [15,34], adipocytes [11,13] or skeletal mus- 
cle [12,14]. Lower concentrations of these substances did 
not affect dGlc transport in CEC (not shown). Note that in 
muscle cells [12,15], as well as in fat cells [11,13], SH-re- 
agents also exert inhibiting effects on glucose transport, 
but at higher concentrations than those required to depress 
glucose transport in CEC. 
Catecholamines, such as adrenaline, dopamine or 
phenylephrine, and serotonin, which were shown to be 
potent stimulators of glucose transport in cardiac tissue 
[9,16,17], did not influence glucose transport in CEC 
(Table 1). 
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Fig. 4. Influence of H I- and H2-receptor antagonists on histamine stimu- 
lation of dGlc uptake in CEC. Cells were preincubated for 10 min with 
either 1 /xM pyrilamine (a specific Hi-antagonist) or with 100 /xM 
cimetidine (a specific H2-antagonist) before histamine (100 /xM) was 
added for another 5 min. dGlc uptake was then measured over a period of 
10 min as described in Section 2. Values are means+S.E.M, from 2-3 
independent experiments. (*: P < 0.05 as compared to corresponding 
control by one-way analysis of variance; #: P < 0.05, as compared to 
histamine stimulated values by paired Student's t-test). 
3.3. Effect of known stimulators of endothelial cell function 
In the following series of experiments, we studied the 
action of metabolic and hormonal effectors on CEC glu- 
cose transport that are known to influence other endothe- 
lial cell functions: bradykinin [18-21], histamine [22-24], 
heparin [25,26] or ADP [27,28]. Treatment of CEC with 
either of these agents did not influence the dGlc uptake 
except for histamine (Table 1). This latter agent evoked a 
significant stimulation of glucose transport (Table 1). The 
extent of this effect, which was highly reproducible, varied 
from a 10% to a 50% increase of dGlc uptake, as com- 
pared to control, depending on the batch of cells. 
3.4. Characterization of the effect of histamine 
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Fig. 3. Concentration dependence of the effect of histamine on dOlc 
uptake in CEC. The cells were exposed to the indicated histamine 
concentrations for 15 min in glucose free HBSS, before dGlc uptake was 
measured over a period of 15 min, as described in Section 2. Data are 
means + S.E.M. from 2-5 independent experiments. Histamine-stimulated 
uptake values were compared to control (no histamine added) by one-way 
analysis of variance for multiple comparisons ( * : P < 0.05; * * : P < 0.01 ;
• **: P<O.O01). 
The concentration dependence of this stimulating effect 
of histamine is illustrated in Fig. 3. Stimulation was half- 
maximal at 12 /zM histamine (as calculated from lin- 
earized data from the dose-response curve shown) and 
reached a maximum at 100 /xM (Fig. 3). The action of 
histamine was rapid, being maximal after 5 min (Table 1). 
Longer preincubation times up to 60 min with histamine 
did not further enhance the rate of dGlc uptake (not 
shown). 
We next addressed the question of which receptor type 
might mediate the observed effect of histamine. Two of the 
three known histamine receptors were reported to be ex- 
pressed in endothelial cells: the H l- and the H2-receptors 
[22,35]. CEC were therefore xposed to either 100 nM 
pyrilamine (a specific Hi-antagonist; K d = 0.8 nM; [22]) 
or with 100 /xM cimetidine (a specific H2-antagonist; 
K d = 800 nM; [22]) for 15 min before histamine (100 ~M) 
was added for another 5 min. Whereas pyrilamine abol- 
ished the stimulation of glucose transport by histamine, 
cimetidine was without effect (Fig. 4), even at concentra- 
tions as high as 1 mM (not shown). Note that neither 
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Fig. 5. Western blot analysis of CEC. A: GLUT1; lane h 50 /xg protein 
of rat brain crude membrane protein, lane 2 :50  ~g of CEC crude 
membrane protein were loaded onto the gel. B: GLUT4; lanes 1 and 2:50 
/xg and 20 /zg of rat heart crude membrane protein, respectively; lanes 3 
and 4:50/zg of CEC crude membrane protein from two independent cell 
lines. Figure shows autoradiographs of representative blots. For further 
details: see Section 2. 
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Fig. 6. Northern blot analysis of CEC. A: GLUT1; lane h 20 /xg of rat 
brain total RNA (used as positive control), lanes 2 and 3:20/xg of CEC 
total RNA from two independent cell cultures. B: GLUT4; lane h 20 /zg 
of rat heart total RNA (positive control), lanes 2 and 3:20 /xg of CEC 
total RNA from two different cell cultures. Glucose transporter mRNA 
appear as 2.8 kb signals. The same blot membranes were re-hybridized 
with a GAPDH cDNA which appears as a 1.4 kb fragment in all lanes. 
For further details: see section 2. 
3.6. Expression of glucose transporters (GLUT1 and 
GLUT4) in CEC 
antagonist affected the basal rate of glucose transport 
under the same conditions (Fig. 4). 
3.5. Effect of combined treatment with histamine and 
glucose deprivation on glucose transport 
In order to compare the acute action of histamine 
described above with the previously described long-term 
stimulation of endothelial cell glucose transport upon glu- 
cose deprivation [2], CEC were incubated at 37°C for 3 h 
in the presence or the absence of glucose before dGlc 
transport was measured. As shown in Table 2, glucose 
deprivation resulted in a 1.3-fold increase in dGlc uptake 
in CEC, as compared to the non-starved control. When 
glucose-deprived cells were exposed to a short (15 min) 
histamine challenge, the rate of glucose transport was a 
little higher than without histamine treatment, but this 
difference did not reach statistical significance (Table 2). 
In view of the effect of histamine on glucose transport 
in CEC, the question arose of the expression of the glucose 
transporter GLUT4. This transporter isoform is present and 
can be recruited in all cell types in which glucose transport 
is subject o acute regulation, not only by insulin [36-38], 
but also by other factors such as catecholamines [39] or 
contraction [40,41]. We therefore xamined the presence of 
this glucose transporter, as well as of the ubiquitous carrier 
isoform GLUT1 in extracts of CEC by Western blot 
analysis. As expected, GLUT1 protein is present in these 
cells (Fig. 5A). Note that in CEC, GLUT1 has a somewhat 
higher apparent molecular weight than in brain membrane 
fractions used as control (Fig. 5A), which might be due to 
different degrees of glycosylation of the transporter p otein 
in these tissues. In contrast, no GLUT4 protein was de- 
tectable in CEC (Fig. 5B). The same results were obtained 
when other anti-GLUT1 and anti-GLUT4 antibodies were 
used for the Western blotting (not shown). In addition, 
Table 2 
Effect of combined treatments with glucose deprivation and histamine on dGlc uptake in CEC 
Treatment Relative dGlc transport Significance 
(in % of control) 
Glucose deprivation 132 + 8 P = 0.028 (vs. control) * 
Histamine 113 -I- 3 P = 0.025 (vs. control) * 
Glucose deprivation + histamine 141 + 12 P = 0.23 (vs. depriv, alone) * * 
Cells were preincubated in the presence ('Control' or 'Histamine') or in the absence of glucose ('Glucose deprivation or Glucose deprivation + histamine') 
at 37°C for 3 h; they were then rapidly washed three times with glucose free HBSS before histamine (100 /xM) was added for 15 rain at room 
temperature, as indicated, dGlc uptake was then measured over a period of 15 min as described in Section 2 (n = 3 in each experiment). Values are 
means + S.E.M. from 3 independent experiments. ( *: as calculated by one-way analysis of variance; * * : as calculated by paired Student's t-test). 
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Northern blot analysis of CEC revealed the presence of 
GLUT1 mRNA in these cells (seen as a 2.8 kb fragment in 
Fig. 6A), whereas no signal corresponding to GLUT4 
mRNA was found (Fig. 6B). 
4. Discussion 
The purpose of the present work was to investigate the 
acute regulation of glucose uptake in endothelial cells from 
a highly insulin-responsive organ such as the heart. To this 
end, isolated endothelial cells from rat hearts (CEC) were 
used. The major new observation of this study is the 
finding that histamine, an important regulator of endothe- 
lial cell function [22-24], causes an increase in glucose 
transport in these cells (Table 1). This effect is rapid 
(being maximal after 5 min of exposure to histamine) 
(Table 1) and persists for at least 60 min (not shown). 
Glucose transport stimulation by histamine does not appear 
to be a sign of non-specific or general stimulation of CEC 
since other factors known to control endothelial cell func- 
tion such as bradykinin [18-21], heparin [25,26], adeno- 
sine diphosphate [27,28], and also catecholamines [42],[43] 
or serotonin [42-44] failed to influence the rate of glucose 
uptake in CEC (Table 1). 
In view of the rapid onset of histamine's effect, de novo 
protein synthesis (e.g., of glucose transporters) is very 
unlikely to be required for the observed rise in glucose 
uptake. However, our attempt o indirectly confirm this 
contention was not successful. Thus, combined treatments 
of CEC with histamine, on the one hand, and with a 
protein synthesis-dependent 'long-term' stimulus of en- 
dothelial cell glucose transport, namely glucose depriva- 
tion [2], failed to reveal a statistically significant additivity 
of the effects of both stimuli (Table 2). A possible xplana- 
tion for this absence of additivity could be a decreased 
sensitivity of glucose-deprived CEC towards the action of 
histamine. 
The results of experiments performed with the selective 
histamine receptor antagonists pyrilamine and cimetidine 
(Fig. 4) clearly indicate that Hi-receptors, but not H2-re- 
ceptors mediate the action of histamine on glucose trans- 
port. In line with this notion, the ECs0 value of transport 
stimulation was about 12 /zM (Fig. 3), which corresponds 
to reported values of ~ 10 -5 M for other Hi-receptor- 
mediated biological responses to histamine [24,45,46], 
whereas H2-receptors are documented as high-affinity 
binding sites (K d ~ 10 -8 M) [22]. 
The other group of potential stimuli that were examined 
in the present work comprises ubstances that rapidly and 
markedly activate the glucose transport system of fat and 
muscle tissues, namely insulin [10,37,38], SH-reagents 
[11-15], catecholamines [9,16,17] and serotonin [16]. The 
lack of stimulatory effect of these agents on the uptake of 
glucose in CEC (Table 1), along with the absence of the 
'insulin-regulatable' glucose transporter GLUT4 mRNA 
(Fig. 6B) and protein (Fig. 5B), seems to confirm the rule 
that GLUT4 expression is a prerequisite to the action of 
insulin and insulin-mimetic agents. As a matter of fact, in 
all studies in which the mechanism of an acute stimulation 
of glucose transport was investigated (in adipocytes, my- 
ocytes or muscle preparations), the recruitment of an intra- 
cellular GLUT4 pool to the plasma membrane was found 
to be involved [37-39,41,47,48]. Thus, the absence of 
GLUT4 in CEC would explain the inability of insulin to 
acutely stimulate glucose transport (Table 1), which con- 
firms previous reports on other types of endothelial cells 
[2,4], and suggests that the insulin-dependent GLUT4 
translocation shown by Vilaro et al. in tissue slices [5] 
most likely does not take place in the endothelium, but in 
the neighbouring fat or muscle cells. 
Furthermore, the lack of GLUT4 in CEC implies that 
the effect of histamine occurs via a different type of 
mechanism than that triggered by insulin in fat and muscle 
or, alternatively, that it involves the transiocation of an- 
other glucose transporter isoform, e.g., GLUT1 which is 
present in CEC (Figs. 5A,6A). Since histamine is known to 
induce shape changes in endothelial cells [22,24], it is 
conceivable that a similar process may play a role here. 
Such shape alterations, which are thought o be responsible 
for histamine's effect on the vascular permeability [22,24], 
were also reported to be mediated by H l-receptors [24]. In 
any instance, the precise mechanism of action of histamine 
on glucose transport in CEC remains to be elucidated. 
Finally, the effect of histamine on glucose uptake may 
have a biological significance in two respects. First, re- 
garding endothelial cell metabolism, one may speculate 
that histamine does not only trigger the responses involved 
in inflammatory processes, but that it improves in parallel 
the supply of these cells with exogenous glucose, and thus 
with metabolic energy necessary to cope with acute chal- 
lenges. In this context, it is worth noting that histamine 
was recently reported to promote glycogenolysis in astro- 
cytoma cells via H ~-receptors with a time- and concentra- 
tion-dependence reminiscent of the characteristics of the 
glucose transport stimulation in CEC observed in the 
present study [46]. Second, the endothelium constitutes a 
diffusion barrier for the transfer of glucose from the blood 
to the interstitial space, and thus to parenchymal cells. 
Alterations at this barrier may become physiologically 
significant if the parenchymal consumption of glucose is 
enhanced and exceeds the endothelial transfer capacity. In 
non-stimulated hearts, the permeability-surface r a prod- 
uct of the capillary endothelium for o-glucose (which 
determines the transendothelial passage of the sugar) only 
exceeds that of the cardiomyocyte membrane by a factor 
of 1.26 (dog hearts) to 3.0 (rabbit hearts) [49]. Considering 
that the rate of cardiomyocyte glucose transport and uti- 
lization can be increased about 5- to 10-fold under various 
conditions (such as increased workload, hypoxia or insulin 
[15,50]), it is conceivable that transcapillary glucose trans- 
fer then becomes rate limiting. In line with this idea, the 
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interstitial glucose concentration of the rat myocardium 
was found to be decreased by interventions known to 
enhance cardiomyocyte glucose uptake, such as /3-adren- 
ergic stimulation [51]. Under such conditions, even a rela- 
tively modest increase in glucose transfer across the lumi- 
nal endothelial cell membrane and subsequent release 
across the abluminal membrane may favour the 
transendothelial passage of the hexose. The present find- 
ings indicating a significant, albeit modest increase of 
glucose transport across the endothelial cell membrane 
supports this possibility. It is however unknown whether 
transendothelial cell transport plays a role of importance in
cardiac tissue in vivo, or whether glucose diffusion occurs 
solely through endothelial c efts. In the brain, however, the 
endothelial barrier is tight and transcapillary exchange of 
glucose is exclusively mediated by endothelial cell glucose 
transporters [52,53], so that potential changes in glucose 
transport at this site could be extremely relevant. Further 
investigations on the glucose transport of endothelial cells 
originating from the brain may therefore be of consider- 
able interest. 
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